These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 27243038)

  • 1. Evaluation of Multiple Immunoassay Technology Platforms to Select the Anti-Drug Antibody Assay Exhibiting the Most Appropriate Drug and Target Tolerance.
    Collet-Brose J; Couble PJ; Deehan MR; Nelson RJ; Ferlin WG; Lory S
    J Immunol Res; 2016; 2016():5069678. PubMed ID: 27243038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solution ELISA as a platform of choice for development of robust, drug tolerant immunogenicity assays in support of drug development.
    Mikulskis A; Yeung D; Subramanyam M; Amaravadi L
    J Immunol Methods; 2011 Feb; 365(1-2):38-49. PubMed ID: 21130095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging Technologies and Generic Assays for the Detection of Anti-Drug Antibodies.
    Partridge MA; Purushothama S; Elango C; Lu Y
    J Immunol Res; 2016; 2016():6262383. PubMed ID: 27556048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of low-affinity anti-drug antibodies and improved drug tolerance in immunogenicity testing by Octet(®) biolayer interferometry.
    Li J; Schantz A; Schwegler M; Shankar G
    J Pharm Biomed Anal; 2011 Jan; 54(2):286-94. PubMed ID: 20869832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic study of the effect of low pH acid treatment on anti-drug antibodies specific for a domain antibody therapeutic: Impact on drug tolerance, assay sensitivity and post-validation method assessment of ADA in clinical serum samples.
    Kavita U; Duo J; Crawford SM; Liu R; Valcin J; Gleason C; Dong H; Gadkari S; Dodge RW; Pillutla RC; DeSilva BS
    J Immunol Methods; 2017 Sep; 448():91-104. PubMed ID: 28625864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a generic immunoassay with drug tolerance to detect immune complexes in serum samples from cynomolgus monkeys after administration of human antibodies.
    Stubenrauch K; Wessels U; Essig U; Vogel R; Schleypen J
    J Pharm Biomed Anal; 2010 Jun; 52(2):249-54. PubMed ID: 20083366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of bioanalytical methods for the quantitation of PEGylated human insulin.
    de Dios K; Manibusan A; Marsden R; Pinkstaff J
    J Immunol Methods; 2013 Oct; 396(1-2):1-7. PubMed ID: 23933323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of antibodies against therapeutic proteins in the presence of residual therapeutic protein using a solid-phase extraction with acid dissociation (SPEAD) sample treatment prior to ELISA.
    Smith HW; Butterfield A; Sun D
    Regul Toxicol Pharmacol; 2007 Dec; 49(3):230-7. PubMed ID: 17869396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of NanoLuc bridging immunoassay for detection of anti-drug antibodies.
    Nath N; Flemming R; Godat B; Urh M
    J Immunol Methods; 2017 Nov; 450():17-26. PubMed ID: 28733215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generic anti-drug antibody assay with drug tolerance in serum samples from mice exposed to human antibodies.
    Stubenrauch K; Mackeben K; Vogel R; Heinrich J
    Anal Biochem; 2012 Nov; 430(2):193-9. PubMed ID: 22935295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel homogeneous Biotin-digoxigenin based assay for the detection of human anti-therapeutic antibodies in autoimmune serum.
    Qiu ZJ; Ying Y; Fox M; Peng K; Lewin-Koh SC; Coleman D; Good J; Lowe J; Rahman A; Yang J; Jiang J; Quarmby V; Song A
    J Immunol Methods; 2010 Oct; 362(1-2):101-11. PubMed ID: 20868690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of miniaturized immunoassays to discovery pharmacokinetic bioanalysis.
    Roman J; Qiu J; Dornadula G; Hamuro L; Bakhtiar R; Verch T
    J Pharmacol Toxicol Methods; 2011; 63(3):227-35. PubMed ID: 21147239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active glucagon-like peptide 1 quantitation in human plasma: a comparison of multiple ligand binding assay platforms.
    Fraser S; Dysinger M; Soderstrom C; Kuhn M; Durham R
    J Immunol Methods; 2014 May; 407():76-81. PubMed ID: 24721392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of drug tolerance in immunogenicity testing by acid treatment on Biacore.
    Sickert D; Kroeger K; Zickler C; Chokote E; Winkler B; Grenet JM; Legay F; Zaar A
    J Immunol Methods; 2008 May; 334(1-2):29-36. PubMed ID: 18304570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimizing NBE PK/PD assays using the Gyrolab Affinity Software; conveniently within the bioanalyst's existing workflow.
    Myzithras M; Bigwarfe T; Waltz E; Li H; Ahlberg J; Rybina I; Low S; Kenny CH; Miglietta J; Kroe-Barrett R
    Bioanalysis; 2018 Mar; 10(6):397-406. PubMed ID: 29451404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of an ultra-sensitive Simoa assay to enable GDF11 detection: a comparison across bioanalytical platforms.
    Myzithras M; Li H; Bigwarfe T; Waltz E; Gupta P; Low S; Hayes DB; MacDonnell S; Ahlberg J; Franti M; Roberts S
    Bioanalysis; 2016 Mar; 8(6):511-8. PubMed ID: 26917343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioanalytical platform comparison using a generic human IgG PK assay format.
    Leary BA; Lawrence-Henderson R; Mallozzi C; Fernandez Ocaña M; Duriga N; O'Hara DM; Kavosi M; Qu Q; Joyce AP
    J Immunol Methods; 2013 Nov; 397(1-2):28-36. PubMed ID: 23994108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Affinity Capture Elution (ACE) assay for detection of anti-drug antibody to monoclonal antibody therapeutics in the presence of high levels of drug.
    Bourdage JS; Cook CA; Farrington DL; Chain JS; Konrad RJ
    J Immunol Methods; 2007 Oct; 327(1-2):10-7. PubMed ID: 17716682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of homogeneous proximity immunoassays for preclinical bioanalysis.
    Eangoor P; Das S; Pucci V
    Bioanalysis; 2020 Dec; 12(24):1757-1766. PubMed ID: 33259228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of a Microfluidic Platform To Evaluate and Predict Reagent Performance in Microtiter Plate-Based Immunoassays.
    Roman J; Ge S; Bouaraphan S; Fink M; Trausch JJ; Verch T
    Anal Chem; 2024 Feb; 96(8):3489-3497. PubMed ID: 38349730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.